生命科学资讯

An archaeal transcription factor bridges prokaryotic and eukaryotic regulatory paradigms

Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss

Tiziana to spin out IL-6 drug into new company, citing Big Pharma's interest in modality

Novocure promotes new CEO, replacing current chief after less than a year

Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge

Morgan Stanley Initiates Coverage on Agilent Technologies (A) wi - GuruFocus

Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug

TXG: Morgan Stanley Downgrades 10x Genomics, Raises Price Target - GuruFocus

Janux sinks on ‘overreaction’ to prostate cancer data; RFK Jr. replaces ACIP chair

As approval date looms, Cytokinetics gears up for David-and-Goliath battle with Bristol Myers

Trends and Tools Transforming Drug Discovery: Five Takeaways from Discover Glo 2025

Helicore stops work on clinical GIP antagonist after Phase 1 results

Agilent Technologies price driven lower by pivotal resistance - Forecast today - 02-12-2025 - Economies.com

Targeted Sequencing Industry Intelligence 2020-2030 Featuring Profiles of MGI Tech, GENEWIZ, Agilent Technologies and Other Leading Companies - Yahoo Finance

Trial Library raises $10M to sell clinical trial matching to insurers

Novo, J&J Alzheimer’s clinical flops teach bruised field valuable lessons

Chinese researchers patent new URAT1 inhibitors

Abbisko Therapeutics divulges new SMARCA2 inhibitors

Chengdu Chipscreen Pharmaceutical describes new WRN inhibitors

New CDK inhibitors disclosed in Adlai Nortye patent